Clinical trial
Hematological Clozapine Monitoring With a Point-of-care Device (CHEMPAQ)
NCT01138618 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hematological Clozapine Monitoring With a Point-of-care Device (CHEMPAQ)
- Lead sponsor
- University of Aarhus
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2010
- Completion date
- May 31, 2011
- Enrollment
- 85 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.